Vernieri, C., Prisciandaro, M., Nichetti, F., Lobefaro, R., Peverelli, G., Ligorio, F., . . . de Braud, F. (2020). Oral Capecitabine-Vinorelbine Is Associated with Longer Overall Survival When Compared to Single-Agent Capecitabine in Patients with Hormone Receptor-Positive Advanced Breast Cancer. Cancers (Basel).
Citación estilo ChicagoVernieri, Claudio, et al. "Oral Capecitabine-Vinorelbine Is Associated With Longer Overall Survival When Compared to Single-Agent Capecitabine in Patients With Hormone Receptor-Positive Advanced Breast Cancer." Cancers (Basel) 2020.
Cita MLAVernieri, Claudio, et al. "Oral Capecitabine-Vinorelbine Is Associated With Longer Overall Survival When Compared to Single-Agent Capecitabine in Patients With Hormone Receptor-Positive Advanced Breast Cancer." Cancers (Basel) 2020.